Advertisement On October 24, 2019, the United States Food and Drug Administration (“FDA”) issued a draft guidance addressing textured breast implants that have been linked to breast implant-associated anaplastic large cell lymphoma (“BIA-ALCL”).” Part of that guidance recommends a Black Box Warning, the most serious level of warning, in the device’s labeling to help ensure women receive … Continue reading FDA Recommends New Warnings for Breast Implants Alleged to Cause Cancer